A Randomized Controlled Study of 4-Day and 7-Day Pantoprazole Quadruple Regimens for Helicobacter Pylori Eradication

李晓宇,魏虹,胡伏莲
DOI: https://doi.org/10.3321/j.issn:1003-3734.2004.05.022
2004-01-01
Abstract:Objective:To compare the efficacy and tolerability of a 4-day therapy with a 7-day therapy of a new pantoprazole quadruple regimen in eradicating Helicobacter pylori (Hp) infection and relieving symptoms. Methods: Patients with Hp-positive peptic ulcer disease as well as gastritis were randomized to receive pantoprazole 40mg, clarithromycin 250mg, amoxicillin 1.0g, and bismuth potas-sium citrate 220mg twice daily for either 4 days or 7 days. Hp status was determined by urease test, histology, culture and 13C-urea breath test. Eradication of Hp and symptomatic relief was determined at week 4. Results:A total of 73 patients were recruited,37 patients in the 4-day group and 36 patients in the 7-day group. All patients in the 4-days group and 34 patients in 7-day group finished the treat-ment. Intention-to-treat Hp eradication rates were 62.2% and 83.3% (P=0. 078) and per protocol Hp eradication rates were 62.2% and 88.2% (P = 0.024) in the 4-day and 7-day groups, respective-ly. Intention-to-treat pain relief rates were 78. 8% and 83. 9% (P = 0. 841) and per protocol pain relief rates were 78. 8% and 89. 7% (P = 0. 312) in 4-day and 7-day groups, respectively. No severe side-effects were found in both groups. Conclusion: The 4-day pantoprazole quadruple regimen shows a higher pain relief rate but a lower Hp eradication rate than the 7-day quadruple regimen,and the 4-day regimen shoud not be used as a first-line therapy in Hp eradication.
What problem does this paper attempt to address?